Innovation Competition (Boston, MA)

Pharmatek Innovation Award

Type:
In-kind products or services
Amount:
$3,000
Summary:

The winning company with orally dosed small molecule drug candidates will receive $3,000 worth of Pharmatek’s unique Hot Rod Chemistry® (HRC®) formulation screening kit and bulk formulation supply.  Click the logo for additionall details on the award.

Requirements:

A company or concept that includes development of a orally dosed small molecule therapeutic. 

EMD Serono Innovation Award

Type:
Cash
Amount:
$5,000
Summary:

In support of innovation and the Boston area life science community, EMD Serono is offering a $5000 cash prize to the top innovaton idea pitch. The winning pitch will be selected by EMD Serono at the event.

Requirements:

Therapeutic modality in our core therapeutic areas of Oncology, Neurodegenerative Diseases, Autoimmune and Inflammatory Diseases, Fertility, and Metabolic Endocrinology. 

LabCentral Innovation Award

Type:
In-kind products or services
Amount:
$4,000
Summary:

We are pleased to offer one month's free membership and a bench space in LabCentral's co-working lab and office facility ($4,000 value). LabCentral provides fully functional lab space, permits, waste handling, plus all reasonably common lab equipment for bioresearch. Access to conference rooms and event space, kitchens, etc. is also included, as is participation in programming specific to the interests of life-sciences startups.

Requirements:

All companies and team that require access to bench space for bioresearch.

Novartis Innovation Award

Type:
In-kind products or services
Amount:
$10,000
Summary:

Novartis is committed to Innovation worldwide, and especially in the Boston area.  We are offering an in-kind award to the winning pitch that combines a strategic review of the team’s business opportunity with selective access to Novartis resources to help validate the underlying technology.  The strategic business plan review and selective access to resources will be managed out of the business development office at Novartis Institutes for Biomedical Research.  This award will result in a report that the team can use to support fund-raising and commercialization that will provide an analysis of the commercial potential of the opportunity and key milestones that the team needs to hit in the process of commercialization.   It will include a description of the resources that Novartis could deploy to support this commercialization effort and suggestions on whom to contact in the investor community to raise capital.  

Requirements:

NIBR’s partnering mission is a 3 pronged approach:

  1. Build internal capabilities – access new biological insights and novel enabling drug discovery technologies 
  2. New therapeutic approaches – access therapeutic products yet to show clinical proof-of –concept but which have the potential to address significant unmet medical need 
  3. Jumpstart new directions – explore and pursue opportunities outside the internal strategy that have the potential to set our future direction